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The intranasal drug delivery route provides exciting expectations regarding the 
application of engineered nanomaterials as nano-medicines or drug-delivery vectors into the 
brain. Among nanomaterials, multi-walled CNTs (MWCNTs) are some of the best candidates 
for brain cancer therapy since they are well known to go across cellular barriers and display 
an intrinsic ability to block cancer cell proliferation triggering apoptosis. Our study reveals 
that microglial cells, the brain macrophages and putative vehicles for MWCNTs into the brain, 
undergo a dose-dependent cell division arrest and apoptosis when treated with MWCNTs. 
Moreover, we show that MWCNTs severely interfere with both, cell migration and 
phagocytosis in live microglia. These results lead to a re-evaluation of the safety of inhaled 
airborne CNTs and provide strategic clues of how to biocompatibilize MWCNTs to reduce 
brain macrophage damage and to develop new nanodrugs  
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1. Introduction 
The intranasal route allows some chemicals, small particles and nanomaterials to enter 
the brain more efficiently than administered systemically.[1,2,3] Among others, manganese 
oxide, [4] silver, [5] cerium oxide, [6,7] ferric[8] and copper[9] oxide or titanium dioxide[10] 
nanoparticles (NPs) have been detected in the brain after exposure by inhalation. Moreover, 
some of these nanomaterials have also been associated with neurotoxicity and 
neurodegeneration after intranasal administration.[9-12] On the other hand, the intranasal 
administration route is so fast and direct that could be exploited to introduce nanomedicines 
into the brain to treat neurodegenerative diseases or brain cancer, avoiding the blood brain 
barrier (BBB).  
This entry route to the central nervous system is still poorly understood, but according 
to the literature the nose-to-brain delivery is mediated by the olfactory bulb (OB) resident 
brain macrophages, known as microglial cells.[13] These cells are continuously surveying the 
brain parenchyma,[14,15] and are strongly chemoattracted by foreign bodies, invading 
pathogens and tumors.[16] After intranasal administration of nanomaterials, microglial cells are 
first recruited to the OB, where they phagocyte the inhaled particles, distributing throughout 
the brain parenchyma afterwards.[17,18] Thus, microglia are key cells to vehicle 
nanotherapeutics into the brain. 
Among all nanomaterials, carbon nanotubes (CNTs) are highly appealing in 
nanotechnology for their very interesting mechanical, thermal and electronic properties. CNTs 
can go across cellular barriers, including the BBB, and can interact with tissues in living 
organisms and enter the cells. Thus they have an enormous potential in medicine as nano-
delivers to introduce genes or drugs into the brain.[19-22]  
CNTs have been claimed not to be inherently cytotoxic to human cells[23] but might 
produce biosynthetic interactions that can interfere with different cellular mechanisms. In 
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particular, these 1D nanostructures have been reported to interact with DNA (2 nm diameter), 
actin microfilaments (7 nm), and microtubules (24 nm). However, not all CNTs produce 
identical cellular effects suggesting intrinsic differences among these fibers. In particular, 
multi-walled CNTs (MWCNTs) display structural similarities to the protofilaments that 
constitute the microtubules (8 nm),[24,25] and have been shown to intermingle with these inside 
the cells, assembling biosynthetic filaments that cause severe proliferation defects that trigger 
cell death.[25] On the other hand, single-walled CNTs (SWCNTs), produce cortical actin 
reorganization and multinucleation in HeLa cells.[23,26] These two different effects reveal that 
different species of nanotubes could selectively interact with either microtubules or actin 
filaments. And this interaction occurs because biological and synthetic filaments share 
numerous properties. They (i) display a similar length-to-width ratio, (ii) they both self-
assemble, (iii) have all a high resiliency, and finally (iv) tend to form bundles that increase 
their strength. But, on the contrary to CNTs, microtubules and actin filaments are highly 
dynamic polymers that continuously undergo assembly and disassembly processes, and this 
dynamic behavior is crucial to play their roles in cell biology.  
Herein we examine the cytoskeletal changes that occur in microglia when exposed to 
MWCNTs and the derived consequences. Our aim is to establish the effects of MWCNTs on 
the viability and function (migration and phagocytosis) of these brain macrophages. 
 
2. Results and Discussion 
 
2.1 MWCNTs characterization and resuspension 
 
MWCNTs were synthesized, purified, characterized and dispersed as described 
elsewhere.[25] Transmission electron-microscopy (TEM) imaging of the as-prepared 
MWCNTs revealed these CNTs displayed 3 to 12 walls, with outer diameter ranging from 5 
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to 15 nm, and inner diameter between 2.5 and 10 nm respectively (Figure 1). The Raman 
spectroscopy characterization of the as-prepared MWCNTs revealed a number of well 
characterized MWCNTs peaks.[27,28] The dispersive disorder induced D band at 1330 cm-1, the 
tangential G band at 1586 cm-1 and the D’ band at 1614 cm-1 were observed. These were 
assigned using the symmetry analysis to the longitudinal optical (LO) mode close to Brillouin 
zone center (Γ). Both, TEM and Raman spectroscopy techniques ruled out impurities or 
contaminants in these MWCNTs samples.[29] 
We prepared a stable dispersion of MWCNTs in horse serum (HS) to be added to the 
culture media. HS is a standard additive in the medium and typically contains proteins and 
lipids shown to interact with the surface of various types of CNTs, including this particular 
type of MWCNTs. A stock resuspension of 60 μg/mL of MWCNTs in HS was prepared as 
reported elsewhere (see the Experimental section and Ref. 25). The 60 μg/mL stock solution 
was used as a ratio 1:10 or 1:100 v/v dilution into the cell culture medium where MWCNTs 
aggregation or precipitation were not observed during the course of the experiments. 
Resuspended MWCNTs were stable for several days at 4º C, and at least for 70 h at 37º C 
diluted in culture medium.  
 
2.2 Low MWCNTs dosages induce cytoskeletal-related cell division defects, while high 
dosages produce S phase cell cycle arrest  
Intracellular MWCNTs were confirmed by confocal Raman scattering and TEM 
(Figure 2). For the study we have used a cell line model named BV2, an immortalized murine 
microglial cell line, commonly used in many macrophage studies and which has been 
previously shown to efficiently internalize MWCNTs.[30] The use of a cell line model in these 
experiments improves reproducibility and reduces primary cell culture variables (such as cell 
diversity, cell death due to tissue handling, individual animal differences, etc.). To obtain the 
Raman scattering spectra, the laser beam was focused on a spot of about 1 μm2 localized 
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within the cytoplasm of a 70 h MWCNT-treated cell (Figure S1, blue spot). Typical G and D 
peaks, together with fingerprints corresponding to the cellular proteins and the growing 
substrate (borosilicate glass) were observed (Figure 2a, red, indicated as “glass substrate”). 
These later peaks were also observable in control cells treated with HS (Figure 2a, black). 
Intracellular MWCNTs were also detectable by TEM on sections of 70 h MWCNT-treated 
cells (Figure 2b, S2). Although identifying single intracellular MWCNTs by TEM in cellular 
sections is highly improbable at the working dosages used, we were able to distinguish 
individual MWCNTs in various cell cytoplasms (Figure 2b), and also occasionally crossing 
the plasma membrane of microglia (Figure S2b). Intracellular bundles of MWCNTs similar to 
those previously characterized for other cell lines were also observed (Figure S2c).[25]  The 
fact that MWCNTs were observed individually in these cells indicates that MWCNTs were 
effectively dispersed in our culture medium and that these fibers were not engulfed as a 
micro-aggregates. 
We investigated the phenotypes of these cells treated for 70 h with a final 0.6 μg/mL 
MWCNTs dose dispersed in the culture medium. For this purpose, cells were fixed, stained 
for nuclear DNA (blue channel) and actin (red channel), and examined by confocal 
microscopy. Projection images of treated microglia revealed that many cells in the culture 
contained fragmented DNA, indicative of cell death by apoptosis (Figure 3a, empty arrows). 
More interestingly, there were large numbers of cells apparently arrested in metaphase, 
displaying supernumerary chromosomes (Figure 3a, filled arrows). This finding, known as 
polyploidy, often results in aberrant cell divisions leading to multi-nucleation or aneuploidy.  
We next characterized by flow cytometry the distribution and total amount of DNA per 
cell. This is a broadly used technique to perform quantitative and qualitative analysis of the 
total DNA content per cell, in approximately 10.000 cells per experiment, allowing the 
simultaneous determination of the percentages of cells at each stage of the cell cycle, and the 
percentage of apoptotic cells (see further details in the Experimental section).[31]  Figure 3b 
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(left panel) displays the cell cycle profiles for the different microglial cell populations (the 
rough cell populations have been colored for simplicity). These profiles reveal that, in control 
cultures, most microglial cells were not undergoing cell division (approximately 70% of the 
total cell population, labeled as G1 and colored in red). Early dividing cells, undergoing DNA 
synthesis (S stage, yellow peak), represented approximately 15-20%. And finally, dividing 
cells, containing twice the total DNA per cell (G2 stage, blue peak) represented less than 10% 
of the total control cells population. In contrast, cells exposed to MWCNTs displayed dose-
dependent cell cycle distribution changes. Low MWCNT dosages (0.6 μg/mL) produced a 
patent misplacement of the cell cycle flow cytometry pattern, suggesting the existence of cells 
containing several nuclei or polyploidy (purple and green peaks) (Figure 3b). These findings 
indicated that MWCNTs could hinder cell division at the final stages of mitosis, allowing 
chromosomal duplication, but interfering with anaphase, telophase or cytokinesis.  [32-36]  
While, on the other hand, high MWCNT concentrations in the culture medium (6 μg/mL) 
produced an earlier mitotic arrest at the S phase of the cell cycle (Figure 3b, bottom-left graph, 
yellow peak) and a severe DNA-fragmentation effect, a typical feature of apoptosis. We 
conclude this double cell-killing effect depends on the actual intracellular MWCNT 
concentrations. While low MWCNT numbers would mostly interfere with actin or 
microtubules, high MWCNT concentrations would invade the whole cell, including the 
nucleus.[37]  As CNTs have been reported to inhibit DNA synthesis[37] and to destabilize the 
DNA structure,[38] MWCNTs entry in the nucleus would interfere with DNA during 
replication, at the “S” (synthesis) stage of the cell cycle, leading to cell dead (Figure 3b). Thus, 
in both instances MWCNTs could trigger apoptosis, firstly, through the activation of the 
spindle assembly checkpoint, arresting cells in mitosis, and secondly, inhibiting DNA 
synthesis.  
 
2.3 Microglia cell migration is severely affected by MWCNTs 
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In macrophages, actin filaments play crucial roles in cell migration and phagocytosis,[40]  
thus we investigated the effect of MWCNTs in both processes. We first quantified cell speed 
and motility in 70 h MWCNT-incubated cells performing time-lapse video microscopy. 
Manual tracking analysis (Figure 4, Video S1 & S2) revealed an average speed in control 
cells of 0.72 μm/min (SD = 3.4), twice the speed of that observed for MWCNT-treated cells 
(0.31 μm/min) (SD = 2.6). Correspondingly, while control cells travelled an average total 
distance of 157 μm during 3.5 h (SD = 34), MWCNT-treated microglia only moved a total 
average distance of 65 μm (SD = 43) (Figure S3). The statistical comparison between these 
two sets of values revealed that MWCNTs significantly interfered with microglial cell speed 
and motility (with t student parameters of 11.7 and 11.4, respectively, in both cases degrees of 
freedom DF = 96 and p = 10-10). Similar speed differences were also observed in BV2 cells 
infected microglia in a 22 h video (see below). As far as we know, this is the first evidence in 
the literature demonstrating that CNTs interfere with cell migration.  
 
2.4 Microglia cell phagocytosis is also hindered by MWCNTs 
As explained above, phagocytic processes regardless of the organism or specific 
molecules concerned, are driven by a finely controlled rearrangement of the actin 
cytoskeleton.[40] Thus, to further confirm that MWCNTs were interfering with the actin 
filaments we examined the phagocytic capacity of these macrophages when exposed to a 
bacterial infection. MWCNT-treated and control BV2 cell cultures, were inoculated with low 
numbers of Listeria monocytogenes in the medium, a bacterium that causes the infection 
listeriosis. The microglial-bacterial interaction was followed by time-lapse video microscopy 
during 22 h. Figure 5a (top) shows how control microglial cells did not allow bacteria to 
grow in the culture plate (Video S3) while cultures that had been previously incubated with 
MWCNTs for 70 h, displayed a conspicuous bacterial growth 22 h post-infection (Insets # 4, 
and # 5, arrow; Video S4). Quantification of bacterial growth (Figure 4b) corroborated these 
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findings while revealing a dose-dependent effect. Therefore, these findings demonstrate that 
MWCNTs also impede the phagocytic capacity of microglia supporting the hypothesis that 
MWCNTs could interfere with actin filament dynamics. 
 
2.5 MWCNTs induce microglial multinucleation in primary cultures  
We also investigated in vitro if microglia were the target cells for MWCNTs in the OB. 
For this purpose we dissected, dissociated and cultured murine OB cellular components. 
These cells, namely neurons, macroglia and microglia, were exposed to 0.6 μg/mL MWCNTs 
in the culture medium for 70 h before fixation and processing (see further details in the 
Experimental section). Figure 6 shows the effects of the addition of MWCNTs in OB nerve 
cells in vitro. Confocal microscopy imaging revealed no obvious degenerative changes (such 
as DNA fragmentation of axonal retraction) in OB neurons at these incubation times, 
suggesting that MWCNTs were not toxic to neurons at these concentrations and exposure 
times.  
On the other hand, microglial cells in MWCNT-treated cultures displayed a clear 
amoeboid morphology, characteristic of activated macrophages and were heavily loaded with 
MWCNTs as observed by differential interference contrast (DIC) microscopy (Figure 6, Inset 
# 6). The large cytoplasmic vacuoles filled with black deposits indicated MWCNTs 
accumulation in the microglial cell cytoplasm (Inset # 6, black arrow). Confocal microscopy 
imaging also showed a patent remodeling of the actin cytoskeleton where no filamentous actin 
(F-actin) was observed. Interestingly, microglial cell bi-nucleation (blue arrows) was also 
observed. These results confirm that, just as reported in vivo,[13,16] in vitro OB microglial cells 
are also the target cells for MWCNTs and behave as highly active macrophages engulfing 
these nanofilaments. 
Finally, microglial multi-nucleation was also investigated and reproduced in primary 
cultures of purified brain microglia. Figure 7a shows a confocal microscopy projection image 
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of three microglial cells, each displaying two nuclei after 70 h incubation with MWCNTs. 
Quantification of mono-nucleated vs. multi-nucleated cells demonstrated a statistically 
significant rise of 22% in multi-nucleation (a significant drop of mono-nucleated cells) in 
MWCNT-treated cultures. Since microglia cell fusion was not observed in time-lapse live cell 
videos, we concluded that this phenotype was the result of a late cell division defect. 
MWCNTs could be interacting biomimetically with the mitotic spindle microtubules as 
described for HeLa cells,[25] or with the actin filaments of the contractile ring, inhibiting the 
progression of the cell cleavage and impeding the separation of the two daughter cells. The 
inhibition of the actin contractile ring, as described for other systems,[26,35-37] typically 
produces a late G2 arrest that makes cells to terminate cell division abruptly bearing two 
nuclei. Hence these results also indicate that in brain purified macrophages these MWCNTs 
interact with actin, stabilizing these filaments in a similar fashion to that described for 
microtubules in HeLa cells.[25] In addition, the patent reorganization of the cytoplasmic actin 
filaments[39] and the existence of small cytoplasmic compact DNA aggregates, just as 
observed for the BV2 cell line, confirmed apoptosis in these primary cultures of brain 





The development of drugs that can enter the brain bypassing the BBB is one of the 
present challenges in medicine and a key obstacle to treat malignant brain tumors or 
neurodegenerative diseases. The intranasal administration route, ideal for these purposes, 
depends on microglia as key players in the distribution of nanomaterials through the brain, 
since these cells are strongly attracted by foreign materials and tumors cells or invading 
pathogens. Among nanomaterials, MWCNTs could represent ideal candidates for brain cancer 
therapy. These fibers are well known to go across cellular barriers and display an intrinsic 
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ability to block cancer cell proliferation triggering apoptosis by interacting with intracellular 
nanofilaments such as microtubules or actin. However, our work demonstrates that these 
properties are a double edge sword since MWCNTs severely impeded microglial 
vehiculization of carbon nanotubes towards the tumor site after intranasal administration.  
On the other hand, these properties might result interesting when considering local brain 
pre- or post-surgical adjuvant therapy. There are several studies that suggest that microglia 
and brain macrophages are a hallmark of human malignant brain tumors and significantly 
contribute to the clinical course and bad prognosis of brain tumors.[41] Thus local MWCNT 
therapy would mostly interfere with the tumor macrophages rather than other local cells 
(Figure 6), producing anti-tumoral effects in situ as shown for other tumors,[42] while 
preserving intact the microglial immune-function in the rest of brain parenchyma. These 
results also provide new clues about the dosages, administration routes and modifications 
required to turn MWCNTs into more biocompatible brain drug delivery vectors. Finally, these 




4. Experimental Section  
MWCNTs characterization, functionalization and dispersion: MWCNTs were synthesized 
following the Catalytic Chemical Vapor deposition method as previously described.[29] These 
particular MWCNTs have been fully characterized by various methods elsewhere.[25] A stable 
MWCNTs suspension was obtained in HS after repeated cycles of vortex mixing followed by 
mild sonication (cycles of 2 s x 5 times, frequency of 38 kHz) as previously described. The 
stability of the suspension and the existence of aggregates were tested through the optical 
absorption spectra in the 400-800 nm range for 20 min after each sonication cycle. The 
suspension stability was checked by measuring the absorbance as a function of time up to 70 
h for different wavelengths.[25] A stock solution containing 0.140 mg MWCNTs dispersed in 
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2.3 mL of HS was prepared (a 60 g/mL). Higher concentrations of MWCNTs were 
impossible to disperse steadily. This MWCNT-HS dispersion was added to the culture. Unless 
otherwise indicated, cells were routinely treated with a final 0.6 g/mL MWCNT dose in the 
culture medium. Identical amounts of total serum (final 10% of both HS and bovine serum) 
were used in all experiments. 
BV2 Cell Cultures: The microglial cell line model known as BV2 has been broadly 
characterized (Pokock, J. M.; Liddle, A.C. Prog. Brain Res. 2001, 132: 555-565). This cell 
line was originally produced by immortalization of murine microglia. This cell line was 
kindly provided by Dr. Pocock, UCL, National Hospital for Neurology & Neurosurgery, 
London UK. BV2 cells grow in DMEM media containing 10% FCS at 37ºC, 5% CO2. 
Primary microglial cell cultures were prepared as previously described.[43] Microglial cells 
were morphologically identified as described elsewhere.[43]   
Optical and Raman Spectroscopy: Visible absorption spectra were recorded with Cary 50 and 
Cary 6000i spectrometers (Varian) operating in the 400-800 nm range. A quartz cuvette of 1 
cm light path was filled with solutions of different concentrations of MWCNTS suspended in 
HS. The unpolarized Raman spectra were taken with a Horiba T64000 triple spectrometer in 
the backscattering geometry, using the 647 nm line of a Coherent Innova Spectrum 70C Ar-
Kr laser and a nitrogen-cooled CCD (Jobin-Yvon Symphony) with a confocal microscope for 
detection. The laser beam was focused down to 1 μm2 spot with a 100X objective and kept 
the power on the sample below 2 mW to avoid laser-heating effects on the probed material 
and the concomitant softening of the observed Raman peaks. MWCNTs produce a 
characteristic Raman spectrum distinguishable of SWCNTs spectrum.[27-28] The radial 
breathing modes (RBM), a Raman feature associated with a small diameter inner tube, is not 
common and can only sometimes be observed when a good resonance condition is 
established. The RBM signal from large diameter tubes is usually too weak to be observable 
and the ensemble average of inner tube diameter broadens the signal. 
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Flow Cytometry: This technique allows the possibility of multiparameter measurements at the 
cellular level in thousands of cells per second.[31] Flow cytometry was performed on a 
suspension of fixed BV2 cells stained with Hoechst, a dye that produces a quantitative 
staining of DNA, using a Becton Dickinson FACS CantoII equipment.. This technique was 
used to determine a blockage in cell proliferation (the DNA content per cell is doubled during 
the cell cycle) and also to quantify the fractional DNA content (“sub-G1” peak), indicative of 
apoptosis. Further details of the technique can be found in Ref. 31. Analysis was performed 
on an average of 10.000 cells per condition (HS-control or HS-MWCNT-treated cells). Data 
quantification was obtained using the FACS Diva software (Becton Dickinson, NJ, USA). 
Analysis has been performed in three sets of experiments at the given concentrations.  
Transmission Electron Microscopy: Morphological characterization of the as-produced 
MWCNTs was performed in a JEOL JEM 2100 microscope operating at 120 kV. Samples for 
TEM were prepared as previously described using ethanol as dispersant and omitting the 
sample centrifugation steps.[25] A drop of this suspension was adsorbed onto a Lacey copper 
grid. Electron microscopy on cells was performed on 70 nm Araldite sections of pellets of 
BV2 cells fixed with 1 % glutaraldehyde in 0.12 M phosphate buffer, washed in 0.12 M 
phosphate buffer, post-fixed in 1 % buffered osmium tetroxide, dehydrated in a graded 
acetone series and embedded in Araldite observed with a JEOL JEM 1011 microscope. 
Sections were mounted on copper grids and stained with lead citrate and uranyl acetate.  
Immunostaining and Confocal Microscopy Imaging: Cells were fixed in 1% glutaraldehyde. 
Antibodies used were anti--tubulin (B512) (Sigma-Aldrich) combined with a secondary 
goat anti-mouse IgG antibody conjugated with Alexa Fluor 488 (Molecular Probes, 
Invitrogen). Actin was stained with Phalloidin–Tetramethylrhodamine B isothiocyanate 
(Sigma-Aldrich) and DNA (nucleus and chromosomes) with Hoechst dye (Bis-benzimide) 
(Sigma-Aldrich). Confocal microscopy images were obtained with a Nikon A1R confocal 
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microscope and processed with the NIS-Elements Advanced Research software. All confocal 
cell images are pseudo-colored. 
Live-Cell Imaging Techniques and Time-Lapse Video Microscopy Experiments. Bacterial 
phagocytosis: MWCNTs were washed from the culture before live-cell imaging. The cell 
migration speed and total track lengths were both measured on 3.5 h time-lapse movies 
obtained at 5 frames/min. Cells were incubated with MWCNTs during 70 h and then washed 
before live cell imaging. This was performed on a Nikon Eclipse Ti live-cell station, using a 
20X Nikon N.A. 0.45. Cell tracking analysis was performed with the NIS-Elements software. 
Trajectory identification was performed manually on at least 200 individual cells per 
condition frame by frame. Infected cultures were imaged during 22 h (at 5 frames/min).  
Quantifications in Figure 5b were made on random images fields obtained at the indicated 
times with the NIS-Elements software. BV2 control and treated cell cultures were incubated 
with L. monocytogenes to provoke microglial activation and bacterial phagocytosis. 
Microglial cultures were exposed to bacteria for 1 h without antibiotic. Next, a bacteriostatic 
gentamicin dose was added to the cultures, allowing a minor time-dependent bacterial 
recovery. Bacterial density in cultures was measured in three random fields of video images 
taken at the indicated time points in 3 different cultures fields. Bacterial cells were quantified 
using the NIS- 2 per photogram at the indicated times. 
Statistical analysis: Unpaired two-tailed Student's t tests were used for the statistical analyses 
of the differences between control and treated cell results. Three sets of experiments were 
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Figure 1. a) Room temperature Raman spectrum of the as-prepared MWCNTs using the 647 
nm line of an Ar-Kr laser. The main peaks are labeled as D, G, and 2D (see text). b) HRTEM 
image of the as-prepared MWCNTs. Absence of undesired impurities in MWCNTs is verified 
by both techniques. 
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Figure 2. a) Raman scattering experiments performed on the cytoplasm of control 70 h 
control and MWCNT-treated microglial cells (black and red profiles, respectively). The 
spectrum displays the typical fingerprints of MWCNTs together with feature peaks that 
correspond to cellular proteins and the growing substrate (borosilicate glass coverslip) (See 
Figure S1). b) TEM section of a microglial cell. (Inset # 1) Individual MWCNTs are observed 
inside the cell cytoplasm within the nuclear cleft. (Inset # 2). Two intracellular filaments 
displaying different diameters are indicated, (i) a microtubule (empty arrow, 24.3 nm), and (ii) 
a MWCNTs (filled red arrow, 7.85 nm). 
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Figure 3. a) Confocal microscopy projection images of 70 h MWCNT-treated BV2 cells 
stained for nuclear DNA (blue channel) and actin (red channel). DNA deposits indicative of 
fragmentation and cell death by apoptosis is observed (Inset # 3, empty arrows). Several 
metaphase cells apparently arrested in the middle of mitosis and displaying polyploidy (highly 
increased number of chromosomes) are indicated (filled arrows). b) Flow-cytometry cell cycle 
profiles of microglia labeled with Hoechst. Different cell cycle stages have been outlined and 
colored as indicated. (top graph) Typical cell cycle of microglia control cells. Non-dividing 
cells (G1, red peak) represent approximately 70% of the total cell population. (mid, bottom 
graphs) Flow-cytometry cell cycles of cultures incubated with final concentrations of 0.6 
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μg/mL and 6 μg/mL (low and high dose respectively) of MWCNTs in the medium. Low 
MWCNT dosages produced a patent increase in polyploidy/multi-nucleation (3.5 % of the 
cells) and a significant rise in the apoptotic rate (grey). These charts also reveal how large 
MWCNT concentrations in the culture medium severely interfere with the DNA synthesis 
process, leading to a patent S cell cycle arrest (37.5 % compared to 16.4 % in controls, yellow 
peak) and to a massive cell death by apoptosis (grey). (Plots: X axis: total DNA content per 
event; Y axis: number of total events). 
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Figure 4. a) Sample 3.5 h tracking trajectories of control and MWCNT-treated microglial 
cells. Trajectories from different cells are labeled in different colors (See also Figure S3). b) 
Representation of individual cell speeds for control cells (right) and MWCNT-treated 
microglial cells (left). (See also the corresponding time-lapse videos S1 & S2 available as 
Supporting information).  
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Figure 5. Microglial response to bacterial infection after 70 h incubation with MWCNTs. a) 
Single microscopy images of a 22 h time-lapse video obtained of microglial cell cultures 
infected with L. monocytogenes at t = 0 and t = 22 h post infection (See also time-lapse video 
S3 & S4 available as Supporting Information). Insets #4 and #5 show bacterial growth in the 
culture 22 h post infection (arrow). b) Representation of the bacterial growth kinetics in these 
cultures at the indicated times. Control cells show a highly efficient bacterial clearance 
capacity, while macrophages treated with both, low and high dosages of MWCNTs for 70 h in 
the culture medium were significantly less successful destroying bacteria.  
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Figure 6. Confocal microscopy projection images of cells cultured from OB and treated with 
HS or MWCNTs for 70 h. No obvious degenerative changes such as nuclear DNA 
fragmentation are observed in neurons (empty arrows). Conversely, microglial cells appeared 
highly vacuolated. (# 6). A disorganized microtubule distribution and binucleation (blue filled 
arrows) are observed. (Inset # 6, right) Same cell observed by differential interference contrast 
(DIC) containing large deposits of MWCNTs in the cell cytoplasm (black arrow). A control 
untreated microglial cell is shown on the bottom right panel.  
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Figure 7. a) Confocal microscopy projection images of purified brain microglial cells treated 
with MWCNTs for 70 h and stained for actin (red channel) and nuclear DNA (blue channel). 
Features of cell death by apoptosis such as F-actin disorganization and the presence of small 
intracellular compact DNA masses are observed (arrows). b) Quantification of the 
percentages of mono-nucleated Vs multi-nucleated cells revealed a significant increase (t = 
4.72; p = 3 x10-5; degrees of freedom, DF = 39) in microglial cell multi-nucleation in primary 
brain cultures treated with MWCNTs. 
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